Literature DB >> 10658020

Enhanced inotropic response to dobutamine in strength-trained subjects with left ventricular hypertrophy.

O E Suman1, D Hasten, M J Turner, M R Rinder, R J Spina, A A Ehsani.   

Abstract

To determine whether strength-trained individuals with physiological concentric left ventricular (LV) hypertrophy exhibit enhanced inotropic responses to catecholamines, we studied 11 bodybuilders, aged 33.0 +/- 2 (SE) yr old, and 10 sedentary healthy subjects, aged 31.3 +/- 2.4 yr old, at baseline and during infusion of incremental doses of dobutamine after atropine. The bodybuilders had larger LV mass, posterior wall and septal wall thicknesses, and wall thickness-to-radius ratio, assessed with two-dimensional echocardiography, than did the sedentary subjects. There was a significant correlation between LV mass and lean body mass irrespective of training status. Baseline LV fractional shortening was similar in the two groups. There was a greater inotropic response to dobutamine in the strength-trained individuals, as evidenced by a steeper slope of the fractional shortening-end-systolic wall stress relationship with a higher y-axis intercept and by a shallower end-systolic wall stress-end systolic diameter relationship without changes in end-diastolic diameter. The heart rate response to dobutamine was attenuated in the strength-trained athletes. There was a significant correlation (r = 0.604, P < 0.05) between the inotropic sensitivity to dobutamine and LV mass normalized for lean body mass in the bodybuilders. The data suggest that concentric LV physiological hypertrophy in the resistance-trained individuals is associated with enhanced inotropic but not chronotropic responses to catecholamines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658020     DOI: 10.1152/jappl.2000.88.2.534

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

Review 1.  Resistance training and cardiac hypertrophy: unravelling the training effect.

Authors:  Mark J Haykowsky; Rudolph Dressendorfer; Dylan Taylor; Sandra Mandic; Dennis Humen
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

2.  Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure.

Authors:  B M Mayosi; A Kardos; C H Davies; F Gumedze; A Hovnanian; S Burge; H Watkins
Journal:  Heart       Date:  2005-04-21       Impact factor: 5.994

3.  Effect of short- and long-term strength exercise on cardiac oxidative stress and performance in rat.

Authors:  Nasser Ahmadiasl; Hamid Najafipour; Farhad Ghadiri Soufi; Afshar Jafari
Journal:  J Physiol Biochem       Date:  2011-11-12       Impact factor: 4.158

4.  Cardiac β-adrenergic responsiveness with exercise.

Authors:  Joseph R Libonati; Scott M MacDonnell
Journal:  Eur J Appl Physiol       Date:  2011-03-15       Impact factor: 3.078

5.  Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.

Authors:  G de Simone; R B Devereux; M Chinali; M J Roman; E T Lee; H E Resnick; B V Howard
Journal:  Nutr Metab Cardiovasc Dis       Date:  2008-07-31       Impact factor: 4.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.